LAUREN ZIMMERMANN: Open Payments
NPI 1972234938 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 14 payments from 10 companies in 2025. Trend: 2023 $230 · 2024 $263 · 2025 $347
Food & beverage: $262Education: $85
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $85 |
| Janssen Biotech, Inc. | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| AVYXA PHARMA, LLC | 1 | $30 |
| TOLMAR, INC. | 2 | $28 |
| Organon LLC | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| IMMUNITYBIO, INC. | 1 | $21 |
| ACCORD HEALTHCARE, INC. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: ERLEADA, Nubeqa, LUTRATE DEPOT, XTANDI, ANKTIVA, Camcevi, XYOSTED, ELIGARD.
Industry payments across MI — which companies pay providers there.
